NEW YORK (360Dx) – Ortho Clinical Diagnostics has signed an agreement to use Sphingotec's Sphingotest Bio-ADM heart failure immunoassay on its automated Vitros immunodiagnostics and integrated systems, the companies announced today.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.